Key points are not available for this paper at this time.
The objective SCORAD and SCORAD showed a fair responsiveness. The MCIDs are an important prerequisite for the interpretation of published eczema trials and for the planning/sample size estimation of future trials.
Schram et al. (Tue,) studied this question.